You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Vitamin D Supplementation During Pregnancy: Is It Necessary?

  • Authors: News Author: Lisa Nainggolan
    CME Author: Charles P. Vega, MD, FAAFP
  • CME Released: 4/12/2013
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 4/12/2014
Start Activity


Target Audience and Goal Statement

This article is intended for primary care clinicians, obstetricians, and other specialists who care for pregnant women.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  1. Assess the use of vitamin D supplements during pregnancy.
  2. Evaluate the effect of maternal 25-hydroxyvitamin D levels during pregnancy on the bone-mineral content of offspring.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Lisa Nainggolan

    Lisa Nainggolan is a journalist for theheart.org, part of the WebMD Professional Network. She has been with theheart.org since 2000. Previously, she was science editor of Scrip World Pharmaceutical News, covering news about research and development in the pharmaceutical industry, and a consultant editor of Scrip Magazine. Graduating in physiology from Sheffield University, UK, she began her career as a poisons information specialist at Guy's Hospital before becoming a medical journalist in 1995. She can be reached at [email protected]

    Disclosures

    Disclosure: Lisa Nainggolan has disclosed no relevant financial relationships.

Editor(s)

  • Brande Nicole Martin, MA

    CME Clinical Editor, Medscape, LLC

    Disclosures

    Disclosure: Brande Nicole Martin, MA, has disclosed no relevant financial relationships.

CME Author(s)

  • Charles P. Vega, MD, FAAFP

    Associate Professor and Residency Director, Department of Family Medicine, University of California-Irvine, Irvine

    Disclosures

    Disclosure: Charles P. Vega, MD, FAAFP, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Joi Tisdale

    CME Program Manager, Medscape, LLC

    Disclosures

    Disclosure: Joi Tisdale, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This enduring material activity, Medscape Education Clinical Briefs has been reviewed and is acceptable for up to 260 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2012. Term of approval is for 1 year from this date. Each Clinical Brief is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of each Clinical Brief. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Note: Total credit is subject to change based on topic selection and article length.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    AAFP Accreditation Questions

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Vitamin D Supplementation During Pregnancy: Is It Necessary?

Authors: News Author: Lisa Nainggolan CME Author: Charles P. Vega, MD, FAAFPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 4/12/2013

Valid for credit through: 4/12/2014

processing....

Clinical Context

The role of vitamin D in pregnancy is controversial, and an editorial by Steer, which accompanies the current article, describes the conflicting evidence and recommendations regarding vitamin D supplementation during pregnancy. First, according to current standards from the US National Institutes of Health, nearly half of pregnant white women might be considered to be vitamin D deficient. The rate of vitamin D deficiency is even higher among pregnant women of color. This had led national societies in England and Canada to recommend the consideration of routine vitamin D supplementation among pregnant women at doses of 400 to 2000 IU daily.

However, other important health agencies recommend against routine testing of 25-hydroxyvitamin D (25[OH]D) levels during pregnancy or routine vitamin D supplementation. Some research has found no association between maternal 25(OH)D levels and outcomes such as recurrent preterm birth, diabetes, or mode of delivery. A systematic review found insufficient evidence regarding the potential benefits and harms of vitamin D supplements during pregnancy to make any meaningful practice recommendations.

The current study by Lawlor and colleagues addresses an important aspect of the controversy of vitamin D in pregnancy: the effect of maternal 25(OH)D levels on the bone density of offspring.

Study Synopsis and Perspective

A large, prospective cohort study has found no association between vitamin-D levels of mothers in pregnancy and the subsequent bone-mineral content of their children at age 9 years. The findings should lead to a reexamination of UK guidelines for vitamin-D supplementation in pregnancy, say the authors.

"We believe...that there is no strong evidence that pregnant women should receive vitamin-D supplementation to prevent low bone-mineral content in their offspring," say Debbie A Lawlor, PhD, from the University of Bristol, United Kingdom, and colleagues in their paper published online March 19, 2013, in the Lancet. However, they caution: "We cannot comment on other possible effects of vitamin D in pregnant women."

In an accompanying comment, Philip J Steer, MD, from Imperial College London, United Kingdom, notes that current UK (National Institute for Health and Clinical Excellence [NICE]) guidelines recommend that all pregnant and breast-feeding women should take a 10-µg vitamin-D supplement every day, despite prior inconsistent results of studies examining vitamin D and various outcomes in pregnancy. Similarly, the Canadian Paediatric Society recommends administering 2000 IU of vitamin D daily to pregnant and lactating women.

But in contrast, the American College of Obstetricians and Gynecologists concluded in July 2011 that "there is insufficient evidence to support a recommendation for screening all pregnant women for vitamin-D deficiency," he notes. The Americans further suggested that "vitamin-D supplementation during pregnancy beyond that contained in a prenatal vitamin should await the completion of ongoing randomized clinical trials," he observes.

Optimum Approach Unclear; Wait for Long-Term Trials

Given the new findings of Dr. Lawlor and colleagues, Dr. Steer says: "The safest approach is probably routinely to supplement pregnant women at greatest risk, as defined by the NICE guidelines: women of south Asian, black African, black Caribbean, or Middle Eastern origin; women who have limited exposure to sunlight (eg, those who are predominantly housebound or are generally fully covered when outdoors); women who eat a diet particularly low in vitamin D (eg, no oily fish, eggs, meat, or vitamin D-fortified margarine or breakfast cereal); and women with a body mass index higher than 30 kg/m² before pregnancy."

"For other women, the optimum approach is unclear, and long-term randomized trials of supplementation are justified," he stresses.

Largest Observational Study to Look at Vitamin D in Pregnancy

Dr. Lawlor's research is the largest-ever observational study of the effects of a mother's vitamin-D levels in pregnancy on her children’s bone health. Very low levels of vitamin D are known to cause rickets, and suboptimal levels can still cause thinning of the bones (osteomalacia), she and her colleagues note.

They assessed vitamin-D levels in 3960 pregnant women, mostly of white European origin, recording data from all 3 trimesters. When their children had reached an average age of 9 years and 11 months, their bone-mineral content — total body less head (TBLH; n=3960) and spinal (n=3196) was assessed using dual-energy X-ray absorptiometry.

Of the women, 2644 (67%) had sufficient, 1096 (28%) insufficient, and 220 (6%) deficient vitamin D, as measured by 25(OH)D concentrations, but TBLH and spinal bone-mineral content did not differ between offspring of mothers in the lower 2 groups vs sufficient 25(OH)D concentration.

No associations with offspring bone-mineral content were found for any trimester, including the third trimester, which is thought to be most relevant (TBLH bone-mineral content confounder-adjusted mean difference –0.03 g per 10.0 nmol/L; spinal bone-mineral content 0.04 g per 10.0 nmol/L).

In an interview with Lancet TV, Dr. Lawlor said this is a cohort study, "and you worry that what you are seeing is explained by confounding. We did a lot of sensitivity analysis, trying to unpick whether somehow we might have gotten [it] wrong, and we absolutely couldn't find anything."

'Normal' Vitamin-D Levels in Pregnancy Not Known

In his comment, Dr. Steer notes that an extensive review published this year concluded that long-term safety data on vitamin-D supplementation "remain limited," and other recent reports suggest "no link between maternal 25 (OH)D concentrations and important pregnancy outcomes such as recurrent preterm birth, diabetes, or mode of delivery." In addition, a 2012 review surmised that the evidence for vitamin-D supplementation in pregnancy was "too limited to draw any conclusions on usefulness and safety and...further rigorous randomized trials are required."

He adds that "a particular difficulty" in deciding who should be supplemented is "the paucity of studies to define the normal range of 25(OH)D...during pregnancy." Dr. Lawlor agreed: "In pregnant women, it's not really clear what a normal level [of vitamin D] should be; when you are pregnant, your whole physiology changes. The evidence for what is normal in pregnancy is not fully understood."

Dr. Steer goes on to explain, however, that black and Asian women routinely have lower concentrations of 25(OH)D, and notes that in published reports about cases of rickets from Canada and the United Kingdom, the majority of affected children are nonwhite. In the Canadian report, 92% of those with rickets had dark skin, and only 1 out of 74 infants with rickets in the UK study was of white European origin (62% were Asian).

Hence his recommendation that women with dark skin and others who might be vitamin-D deficient due to diet or other reasons probably should still routinely receive vitamin-D supplements in pregnancy.

Dr. Lawlor and colleagues as well as Dr. Steer have disclosed no relevant financial relationships.

Lancet. Published online March 19, 2013. Abstract

Study Highlights

  • Study data were drawn from the Avon Longitudinal Study of Parents and Children, which recruited 14,541 pregnant women in 1991-1992. There were 13,678 singleton live-born infants as a result of these pregnancies.
  • Women participating in the study had 25(OH)D levels measured during pregnancy. Testing was not limited to a particular trimester of pregnancy.
  • Offspring in the study cohort had 25(OH)D levels measured at age 9 or 10 years, along with dual x-ray absorptiometry. Dual x-ray absorptiometry measured bone-mineral content of the TBLH and spine specifically.
  • The main study result was the relationship between the concentration of maternal 25(OH)D and the bone-mineral content of offspring. This result was adjusted to account for maternal demographic factors, body mass index, and smoking as well as the body mass index and fat mass of children.
  • 3960 mothers and their offspring were examined in the current study. The mean age of offspring at the time of dual x-ray absorptiometry and 25(OH)D testing was 9.9 years. Most 25(OH)D levels were drawn during the third trimester in the maternal sample.
  • The mean levels of 25(OH)D varied between 55 and 67 nmol/L, depending on the timing of the test during pregnancy. The mean level of 25(OH)D increased with each trimester. Two thirds of the maternal study sample was considered to have sufficient vitamin D levels.
  • Exposure to ultraviolet B light had minimal effect on maternal 25(OH)D levels.
  • Older mothers had higher 25(OH)D levels, and greater parity also correlated with higher 25(OH)D levels. Nonwhite race and smoking were associated with lower 25(OH)D levels.
  • Maternal 25(OH)D levels in any trimester were not significantly associated with offspring bone-mineral content. Similarly, maternal vitamin D deficiency did not predispose children to lower bone-mineral content.
  • A weak association was observed between maternal 25(OH)D and offspring 25(OH)D levels.

Clinical Implications

  • Many pregnant women may be considered to be deficient for vitamin D, particularly women of color. Conflicting evidence exists as to whether 25(OH)D levels or vitamin D supplementation is important for pregnancy and childhood outcomes. Nonetheless, some national societies recommend the consideration of routine supplementation with vitamin D during pregnancy.
  • In the current study by Lawlor and colleagues, maternal 25(OH)D levels in any trimester failed to significantly affect the bone-mineral content of offspring.

CME Test

  • Print